WCG Executive and Leadership Team

Anthony Doyle, the Chief Financial Officer at WCG, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company maintains the resources necessary to support large-scale clinical trial operations. This leadership role involves evaluating investment opportunities that enhance the service portfolio for biopharmaceutical clients. By optimizing cost structures and revenue cycles, Doyle drives long-term financial stability and growth. The Chief Financial Officer collaborates with other executives to align budgetary priorities with the overarching mission of improving trial quality. Through rigorous financial oversight, Anthony Doyle provides the transparency required for institutional stakeholders. This disciplined approach to capital management enables the company to expand its footprint in the global research market while maintaining operational excellence.

Todd Joron, the Co-Founder & Wcg Imaging President & Chief Operating Officer at WCG, manages the daily execution of clinical trial imaging services and operational workflows. Overseeing the integration of imaging technology into research protocols, the Co-Founder & Wcg Imaging President & Chief Operating Officer ensures that data collection meets the highest standards of accuracy. This leadership role involves scaling operational capacity to meet the demands of global biopharmaceutical trials. By refining internal processes, Joron drives efficiency and reduces the time required for therapy development. The Co-Founder & Wcg Imaging President & Chief Operating Officer collaborates with the executive team to ensure seamless service delivery across all research sites. Through the application of specialized imaging expertise, Todd Joron supports the company's commitment to quality. This operational focus directly impacts the speed and reliability of clinical research outcomes.

Cynthia Carter, the President, MI & I at WCG, directs the specialized operations and strategic initiatives within the medical imaging and informatics division. Overseeing the deployment of advanced informatics tools, the President, MI & I ensures that clinical trial data is processed with precision and speed. This leadership role involves managing the intersection of technology and research to improve trial outcomes for biopharmaceutical clients. By optimizing informatics workflows, Carter drives efficiency in data analysis and reporting. The President, MI & I collaborates with the executive team to ensure that technological advancements align with the company's commitment to quality. Through the leadership of this division, Cynthia Carter enables the organization to provide critical insights that accelerate the development of new therapies. This focus on informatics ensures the company remains at the forefront of clinical research innovation.

Terri Moench, the President, Clinical Research Solutions at WCG, directs the delivery of comprehensive research services to biopharmaceutical companies and institutions. Overseeing the operational teams responsible for trial facilitation, the President, Clinical Research Solutions ensures that every project meets the highest quality standards. This leadership role involves scaling service delivery to support the diverse needs of global clinical trials. By refining research methodologies, Moench drives efficiency and improves the overall trial experience for patients. The President, Clinical Research Solutions collaborates with the executive team to align service capabilities with the evolving demands of the industry. Through the management of these critical research solutions, Terri Moench enables the company to accelerate the development of new therapies. This focus on operational excellence ensures the organization remains a leader in the clinical research field.

Michael Passanante, the Chief Marketing Officer at WCG, directs global brand strategy and market positioning for clinical trial services. Overseeing demand generation and corporate communications, the Chief Marketing Officer ensures alignment between service offerings and the evolving needs of biopharmaceutical clients. This leadership role involves architecting digital engagement programs that highlight the company's expertise in trial efficiency. By analyzing market trends across North American and international sectors, Passanante drives brand awareness and competitive differentiation. The Chief Marketing Officer collaborates with the executive team to translate complex research solutions into clear value propositions for CROs and institutions. Through data-driven campaigns, Michael Passanante expands the reach of the organization, ultimately supporting the broader goal of accelerating the development of new therapies for patients worldwide.

Paul Mancinelli, the Chief Technology Officer at WCG, architects the digital infrastructure supporting clinical trial management and data integrity. Overseeing software development and cybersecurity initiatives, the Chief Technology Officer ensures that all platforms meet the rigorous compliance standards required by global regulatory bodies. This leadership role involves integrating advanced analytics into the service model to enhance trial efficiency for biopharmaceutical companies. By modernizing internal systems, Mancinelli drives operational scalability across the enterprise. The Chief Technology Officer works closely with the Board to prioritize investments in emerging technologies that streamline research workflows. Through the implementation of robust cloud solutions, Paul Mancinelli secures the technological foundation necessary for high-stakes clinical research. This focus on innovation allows the organization to maintain a leading position in the competitive landscape of medical development.

Lisa Calicchio, the Senior Vice President and Chief Human Resources Officer at WCG, directs talent acquisition, organizational development, and employee engagement strategies. Overseeing the human capital lifecycle, the Senior Vice President and Chief Human Resources Officer ensures the company attracts and retains top-tier experts in clinical research and technology. This leadership role involves fostering a culture of innovation and compliance that supports the company's mission to improve trial efficiency. By implementing comprehensive training programs, Calicchio drives professional growth across the workforce. The Senior Vice President and Chief Human Resources Officer works with the executive team to align personnel capabilities with the strategic goals of the organization. Through the development of inclusive workplace policies, Lisa Calicchio strengthens the operational capacity of the firm. This focus on human capital ensures the company remains a preferred partner for biopharmaceutical clients.

Antonio Castillo, the Director, Chief Revenue Officer Partnerships at WCG, architects strategic alliances with CROs and research institutions to expand market reach. Overseeing partnership development, the Director, Chief Revenue Officer Partnerships ensures that the company's service offerings integrate effectively into the broader clinical trial ecosystem. This leadership role involves identifying new revenue streams and strengthening existing client relationships. By aligning partnership goals with the company's mission, Castillo drives sustainable growth in the biopharmaceutical sector. The Director, Chief Revenue Officer Partnerships works with the executive team to negotiate complex agreements that enhance service delivery. Through the cultivation of long-term collaborations, Antonio Castillo secures the company's position as a vital partner in medical research. This focus on strategic revenue growth supports the organization's ability to facilitate the development of new treatments and therapies.

Jared Zane, the Chief Legal Officer & Corporate Secretary at WCG, directs all legal affairs, regulatory compliance, and corporate governance matters. Overseeing the legal framework for clinical trial services, the Chief Legal Officer & Corporate Secretary ensures that the company adheres to international standards and ethical guidelines. This leadership role involves managing risk and protecting the intellectual property of the organization. By providing counsel on complex regulatory issues, Zane drives the company's ability to operate safely in the global research market. The Chief Legal Officer & Corporate Secretary works with the Board to maintain transparency and accountability in all corporate actions. Through the management of legal risks, Jared Zane supports the company's mission to facilitate the development of new treatments. This focus on compliance ensures that the organization maintains the trust of biopharmaceutical partners and regulatory agencies.